About this episode
Extreme thinness is on the rise since the introduction of GLP1s — it has been hard to miss the parade of skinnier-than-ever celebrities. Now, Health Canada has approved the first two generic versions of Ozempic, and more are likely coming, driving down the price and making them even more accessible. It is raising complicated questions about what it means to be fat, thin, and healthy in the age of Ozempic.
Get every episode summarized
Each time The Current publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Current
Remembering the desperate search for the missing on 9/11
The Current
A Canada-U.S. friendship forged in the aftermath of 9/11
The Current
Rick and Amanda Hansen reflect on the “Man in Motion” Tour
The Current
A Canadian and an American 9/11 survivor tell their stories
The Current